HOME >> MEDICINE >> NEWS
Delivery of aid to Africa: Changes needed to ensure money reaches poor

Without major changes to the way external aid is delivered to Africa it will be impossible to reach the Millennium Development Goals for most of the continent, state the authors of a comment in this week' s issue of The Lancet.

A recent survey showed that 83% of British people had no confidence that financial aid given to Africa would be spent wisely. Many specialists also agree that translating increased aid into better health and stronger economies in the poorest nations will be difficult. Malcolm Potts (University of California, USA) and Claus Janisch (KfW Banking Group, Frankfurt, Germany) argue that one way to target money more accurately is thorough output-based assistance (OBA). With OBA an independent management agency sells vouchers to the target population. Individuals can then take their low-cost vouchers to a government or mission hospital, or to an accredited private doctor, who will then cash in the voucher for a previously agreed item-of-service payment.

Dr Potts and Dr Janisch state: "Competition for clients improves quality of care, and cashflow direct to providers devolves financial decisions to the lowest appropriate level. Most importantly, in many input-based projects, 20% or less of the money allocated actually reaches the poor. OBA can reverse this equation."

"The health situation in Africa is deteriorating and without major challenges in external aid and internal administrative structures, it will be impossible to reach the Millennium Development Goals for most of the continent," they add.


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
13-Oct-2005


Page: 1

Related medicine news :

1. NIH holds state-of-the-science conference: Caesarean Delivery on Maternal Request, March 27-29, 2006
2. Delivery of routine preventive services suboptimal for medicare beneficiaries
3. Africa: International volunteer impact small, but significant
4. West Africa: meningitis epidemics driven by the wind
5. Changes in brain density can help predict schizophrenia
6. Changes in brain, not age, determine ones ability to focus on task
7. Changes advocated in license renewals for elderly drivers
8. Changes in brain receptors linked to seizures and anxiety during the menstrual cycle
9. Institute of Medicine news: Changes needed in WIC program
10. Steps needed to reduce smoking in the US
11. New treatments needed for irritable bowel syndrome

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Delivery aid Africa Changes needed ensure money reaches poor

(Date:4/23/2014)... of endogenous neural precursor cells cannot alone compensate ... the perspective of neural plasticity, Dr. Yun Xiang ... observed the effects of functional electrical stimulation treatment ... of basic fibroblast growth factor and epidermal growth ... side. The researchers found that functional electrical stimulation ...
(Date:4/22/2014)... (Chicago) A recently FDA-approved device has been shown ... as much as 50 percent. When coupled with an ... Rush, the device facilitated the complete elimination of seizures ... in the decade-long clinical trials. , That,s good news ... in the U.S. living with epilepsy whose seizures can,t ...
(Date:4/22/2014)... all lung cancers are small cell lung cancers ... to chemotherapy. However, researchers at Virginia Commonwealth University ... the mechanisms leading to this resistance that may ... primarily by mediating B-cell lymphoma 2 (Bcl-2) family ... Depending on their function, this family of proteins ...
(Date:4/22/2014)... Hopkins scientists have found a way to block abnormal ... of atherosclerosis, the main cause of heart attacks and ... The condition develops when fat builds inside blood vessels ... greatly reducing their ability to feed oxygen-rich blood to ... series of experiments, described April 7 in the journal ...
(Date:4/22/2014)... massive health care spending, a new RAND study concludes ... incentivize pharmaceutical companies and device makers to develop products ... medical technologies and their use, a new study suggests ... medical devices get created in the first place. The ... as little loss of health as possible and to ...
Breaking Medicine News(10 mins):Health News:Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy 2Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 4Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3
(Date:1/15/2014)... PHILADELPHIA , Jan. 15, 2014  Echo Therapeutics, Inc. ... company developing its Symphony® CGM System as a non-invasive, ... Robert F. Doman , Executive Chairman and Interim CEO ... Capital Markets, Tenth Annual Equity Conference. ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... and Market Analysis to 2022 ... Dermatitis - India Drug Forecast and Market ...
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: